House approves language to protect 340B Program

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The House of Representatives has approved bipartisan language “to highlight the need to protect the integrity of the 340B program by halting pharmaceutical manufacturers’ unlawful actions that have resulted in overcharges to 340B covered entities.” 

The appropriations bill amendment, authored by Reps. Abigail Spanberger (D-Va.) and David McKinley (R-W.V.), pertains to drug companies that have stopped offering required discounts to safety-net hospitals, health centers, and clinics on drugs dispensed at community-based pharmacies.

“My 340B-related amendment sends a message to big pharmaceutical companies: Stop hiking drug prices on consumers and discriminating against our 340B providers and pharmacies,” Spanberger said in a House floor speech.

“The actions of several drug companies to deny 340B discounts for drugs dispensed at community pharmacies are harming safety-net providers and the patients they serve while increasing drugmakers’ profits,” 340B Health President and CEO Maureen Testoni said in a statement.

Table of Contents

YOU MAY BE INTERESTED IN

U.S. Deputy Secretary for Health and Human Services, Andrea Palm, and Sweden's Minister for Health Care, Acko Ankarberg Johansson, signing the agreement. Credit: Joel Apelthun/Government Offices of SwedenThe United States and Sweden signed an agreement to step up collaborations in science and technology by focusing on cancer research.

Login